Early Bactericidal Activity of Moxifloxacin in Treatment of Pulmonary Tuberculosis: a Prospective, Randomized Study

Moxifloxacin is the most active fluoroquinolone against Mycobacterium tuberculosis in vitro. However, data about the efficacy in patients are not available. We enrolled 17 patients with tuberculosis in a prospective, randomized study. After 5 days of monotherapy with either moxifloxacin or isoniazid...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Pletz, Mathias W. R., De Roux, Andres, Roth, Andreas, Neumann, Karl-Heinz, Mauch, Harald, Lode, Hartmut
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Clinical Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC353154/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14982764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.3.780-782.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!